Indivior PLC is a global healthcare company focused primarily on the treatment of addiction and serious mental health conditions
It specializes in developing and commercializing innovative pharmaceutical products designed to support individuals struggling with substance use disorders, particularly opioid addiction. The company's portfolio includes medications that facilitate recovery by reducing cravings and withdrawal symptoms, thereby helping patients manage their addiction effectively. Indivior is committed to advancing research and development in this field, aiming to improve patient outcomes and support the global effort to combat addiction through comprehensive treatment solutions.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Indivior's 2025 outlook missed estimates, citing Suboxone sales erosion. The company plans $100 million in cost cuts, with $50M reinvested in Sublocade.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC (“Indivior” or “the Company”) (NASDAQ: INDV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The Law Offices of Frank R. Cruz reminds investors of the upcoming October 1, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) securities between February 22, 2024 and July 8, 2024, inclusive (the “Class Period”).
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of securities of Indivior PLC (NASDAQ: INDV) between February 22, 2024 and July 8, 2024, both dates inclusive (the “Class Period”). Indivior PLC is a pharmaceutical company.
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Indivior PLC (NASDAQ: INDV), CrowdStrike Holdings, Inc. (NASDAQ: CRWD), DXC Technology Company (NYSE:DXC), and Five Below, Inc. (NASDAQ: FIVE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Indivior PLC (NASDAQ: INDV), CrowdStrike Holdings, Inc. (NASDAQ: CRWD), DXC Technology Company (NYSE:DXC), and Five Below, Inc. (NASDAQ: FIVE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Indivior PLC (NASDAQ: INDV) securities between February 22, 2024 and July 8, 2024. Indivior is a global pharmaceutical company that develops, manufactures, and markets drugs to treat opioid use disorders (“OUD”) and serious mental illnesses.
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Indivior PLC (NASDAQ: INDV), CrowdStrike Holdings, Inc. (NASDAQ: CRWD), DXC Technology Company (NYSE:DXC), and Five Below, Inc. (NASDAQ: FIVE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Indivior PLC (NASDAQ: INDV), CrowdStrike Holdings, Inc. (NASDAQ: CRWD), DXC Technology Company (NYSE:DXC), and Five Below, Inc. (NASDAQ: FIVE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
SAN DIEGO, Sept. 13, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of Indivior PLC (NASDAQ: INDV) (“Indivior” or the “Company”) securities between February 22, 2024 and July 8, 2024, inclusive (the “Class Period”), charging the Company and certain senior executives with violations of the federal securities laws (collectively, “Defendants”).
NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Indivior PLC (NASDAQ: INDV), CrowdStrike Holdings, Inc. (NASDAQ: CRWD), DXC Technology Company (NYSE:DXC), and Five Below, Inc. (NASDAQ: FIVE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
